Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review.

Hodge WG, Lachaine J, Steffensen I, Murray C, Barnes D, Foerster V, Ducruet T, Morrison A.

Br J Ophthalmol. 2008 Jan;92(1):7-12. Review.

PMID:
18156371
[PubMed - indexed for MEDLINE]
2.

Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.

Bournias TE, Lai J.

Ophthalmology. 2009 Sep;116(9):1719-24. doi: 10.1016/j.ophtha.2009.03.050. Epub 2009 Jul 9.

PMID:
19592108
[PubMed - indexed for MEDLINE]
3.

Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.

Simmons ST; Alphagan/Trusopt Study Group.

Clin Ther. 2001 Apr;23(4):604-19.

PMID:
11354394
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized, controlled trials.

Cheng JW, Xi GL, Wei RL, Cai JP, Li Y.

J Ocul Pharmacol Ther. 2009 Feb;25(1):55-64. doi: 10.1089/jop.2008.0080.

PMID:
19232016
[PubMed - indexed for MEDLINE]
5.

24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.

Konstas AG, Karabatsas CH, Lallos N, Georgiadis N, Kotsimpou A, Stewart JA, Stewart WC.

Ophthalmology. 2005 Apr;112(4):603-8.

PMID:
15808251
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.

Katz LJ, Simmons ST, Craven ER.

Curr Med Res Opin. 2007 Dec;23(12):2971-83. Review.

PMID:
17949534
[PubMed - indexed for MEDLINE]
7.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406
[PubMed - indexed for MEDLINE]
8.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
[PubMed - indexed for MEDLINE]
9.

Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group.

J Glaucoma. 2005 Apr;14(2):161-7.

PMID:
15741820
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of brimonidine, dorzolamide and latanoprost as adjunctive therapy in primary open angle glaucoma.

Sodhi PK, Pandey RM, Ratan SK.

Int J Clin Pract. 2003 Dec;57(10):875-8.

PMID:
14712889
[PubMed - indexed for MEDLINE]
12.

Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.

Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2917-23.

PMID:
16799034
[PubMed - indexed for MEDLINE]
Free Article
13.

Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

Li N, Chen XM, Zhou Y, Wei ML, Yao X.

Clin Experiment Ophthalmol. 2006 Nov;34(8):755-64.

PMID:
17073898
[PubMed - indexed for MEDLINE]
14.

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25.

PMID:
18364402
[PubMed - indexed for MEDLINE]
15.

Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma.

Oztürk F, Ermiş SS, Inan UU, Aşagidag A, Yaman S.

J Ocul Pharmacol Ther. 2005 Feb;21(1):68-74.

PMID:
15718830
[PubMed - indexed for MEDLINE]
16.

Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.

Fung AT, Reid SE, Jones MP, Healey PR, McCluskey PJ, Craig JC.

Br J Ophthalmol. 2007 Jan;91(1):62-8. Epub 2006 Sep 6. Review.

PMID:
16956912
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J.

Br J Ophthalmol. 2009 Mar;93(3):316-21. doi: 10.1136/bjo.2007.135111. Epub 2008 Nov 19. Review.

PMID:
19019922
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.

Maruyama K, Shirato S.

J Glaucoma. 2006 Aug;15(4):341-5.

PMID:
16865013
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of latanoprost in eyes with uveitic glaucoma.

Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G.

Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):775-80. doi: 10.1007/s00417-009-1036-3. Epub 2009 Jan 28.

PMID:
19184081
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk